NovoCure Limited (NVCR)

Last Closing Price: 15.63 (2024-03-28)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

NovoCure Limited (NVCR) had Revenue of $133.78M for the most recently reported fiscal quarter, ending 2023-12-31.

Figures for fiscal quarter ending 2023-12-31
Income Statement Financials
Revenue
$133.78M
$-47.08M
$32.56M
$101.23M
$185.50M
$-51.72M
$13.18M
$-38.53M
$-38.53M
$-47.08M
$-47.08M
$-47.08M
$-47.08M
$-51.72M
$-56.26M
106.39M
106.39M
$-0.45
$-0.45
Balance Sheet Financials
$1.03B
$62.86M
$111.72M
$1.15B
$179.12M
$568.82M
$604.52M
$783.63M
$362.50M
$362.50M
$362.50M
107.08M
Cash Flow Statement Financials
$-73.34M
$184.15M
$15.79M
$115.83M
$242.56M
$126.73M
$115.61M
--
--
Fundamental Metrics & Ratios
5.78
--
--
0.61
1.57
75.67%
-38.66%
-38.66%
--
-28.80%
-35.19%
$-100.43M
--
--
--
0.12
0.85
1.59
56.44
-12.99%
-12.99%
-4.11%
-5.06%
$3.39
$-0.94
$-0.69